April 9, 2025 — Merit Medical Systems has announced the U.S. commercial release of its Ventrax Delivery System.

Ventrax is intended to facilitate placement of devices used in ablation procedures commonly performed to treat an abnormally fast heartbeat known as ventricular tachycardia (VT). Ventricular arrhythmias, which include VT, are believed to cause approximately three out of four sudden cardiac deaths, which result in an estimated 184,000–450,000 lives lost in the United States each year.¹

April 15, 2025 – DESKi recently announced FDA clearance for 

On April 9, 2025, the world’s first multisector advocacy movement dedicated to stroke — the Global Stroke Action Coalition — issued an urgent call to action to address growing inequities in stroke. Already a leading cause of death and disability, without intervention, the global burden of stroke is projected to rise by a further 50% over the next 25 years, claiming 100 million lives and costing US$1.6 trillion each year.  

April 1, 2025 — UltraSight recently announced the presentation at the American College of Cardiology (ACC) Annual Meeting 2025 of three abstracts highlighting promising study findings using its AI-driven ultrasound platform. Conducted in collaboration with Mayo Clinic, the studies substantiate that UltraSight’s Real-Time Guidance software enables novice users — with no prior ultrasound experience — to acquire diagnostic-quality cardiac ultrasound images. 

Advanced RCM Strategies

Cardiology practices face mounting financial pressures — rising operational costs, declining reimbursements, and complex billing regulations. Without an optimized revenue cycle management (RCM) strategy, even high-volume practices struggle with cash flow gaps, claim denials and administrative inefficiencies.

April 10, 2025 — The American College of Cardiology’s (ACC’s) five-year Strategic Plan includes a major initiative focused on transforming care delivery in new areas and recognizing the importance of delivering care within the communities where patients reside.1 As part of this initiative, the ACC and MedAxiom, an ACC Company focused on cardiovascular organizational improvement solutions, are partnering on a series of care transformation resources designed to provide a framework for health systems to effectively integrate novel paradigms of ca

April 9, 2025 — Idorsia Ltd recently announced that the US Food & Drug Administration (FDA), after having released Tryvio from its REMS (Risk Evaluation and Mitigation Strategy) requirement (

April 7, 2025 — CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S. Food and Drug Administration (FDA) clearance for its ViaOne system. This device is designed to enable safe and precise access to the heart’s surface (pericardial space) for both diagnostic and therapeutic interventions — without using an exposed needle. By eliminating the need for an uncontrolled sharp needle, ViaOne mitigates the risk of heart perforation, a well-recognized complication associated with current percutaneous techniques.

April 4, 2025 — Viz.ai has been named an Award Winner in the 2025 Edison Awards, for the third year in a row.

April 3, 2025 — Tower Health and Siemens Healthineers  recently announced a 10-year agreement focused on equipment enhancement, technology modernization and improving clinical experience for patients. This Value Partnership1 will bring comprehensive improvements in diagnostic imaging and digital intelligence tools to cardiology, radiology and oncology across the Tower Health system.

Tower Health is a regional integrated healthcare system that offers compassionate, high-quality, leading-edge healthcare and wellness services to communities in Pennsylvania.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now